LLMpediaThe first transparent, open encyclopedia generated by LLMs

Journal of Veterinary Pharmacology and Therapeutics

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Alastair Cribb Hop 4
Expansion Funnel Raw 59 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted59
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Journal of Veterinary Pharmacology and Therapeutics
TitleJournal of Veterinary Pharmacology and Therapeutics
AbbreviationJ. Vet. Pharmacol. Ther.
DisciplineVeterinary pharmacology, Veterinary therapeutics
LanguageEnglish
EditorPeter Lees
PublisherWiley-Blackwell
CountryUnited Kingdom
History1978–present
FrequencyBimonthly
OpenaccessHybrid
Impact1.5
Impact-year2022
ISSN0140-7783
EISSN1365-2885
OCLC3915957
Websitehttps://onlinelibrary.wiley.com/journal/13652885
LCCN79643365
CODENJVPTD9

Journal of Veterinary Pharmacology and Therapeutics is a prominent international scientific periodical dedicated to advancing the study of drug actions and therapeutic applications in animals. It serves as a critical forum for disseminating original research on pharmacokinetics, pharmacodynamics, and clinical drug use across diverse species. The journal is published by Wiley-Blackwell and is the official publication of the American Academy of Veterinary Pharmacology and Therapeutics and the European Association for Veterinary Pharmacology and Toxicology. Its content supports veterinarians, researchers, and regulatory scientists in optimizing medicinal treatments for companion animals, livestock, and wildlife.

History and scope

The journal was established in 1978, emerging during a period of significant growth in the specialized field of veterinary pharmacology. Its founding was closely associated with the professional activities of the American Academy of Veterinary Pharmacology and Therapeutics, which sought a dedicated platform for scholarly exchange. The scope encompasses all aspects of drug therapy in animals, including analytical methods for drug detection, studies on antimicrobial resistance, residue depletion in food animals, and the pharmacology of agents used in equine medicine and bovine health. It also publishes research on veterinary anesthesia, pain management, and regulatory science pertinent to agencies like the Food and Drug Administration and the European Medicines Agency.

Abstracting and indexing

The journal is comprehensively abstracted and indexed in major scientific databases, ensuring wide dissemination of its research. Key indexing services include the Science Citation Index Expanded, Scopus, PubMed, and the BIOSIS Previews. It is also covered by CAB International and Chemical Abstracts Service. This broad indexing in resources like EMBASE and Google Scholar enhances its visibility and accessibility to the global scientific community, facilitating citations and supporting evidence-based practice in veterinary medicine and related biomedical research.

Editorial board and peer review

The journal operates under the leadership of an international editorial board comprising experts from institutions like the Royal Veterinary College, University of California, Davis, and Massey University. The editor-in-chief is Peter Lees, a renowned figure in veterinary pharmacology. The peer-review process employs a rigorous single-blind system managed through the ScholarOne Manuscripts platform, involving reviewers from academia, industry, and government bodies such as the United States Department of Agriculture. This process upholds high standards of scientific validity and ethical publication, aligning with guidelines from the Committee on Publication Ethics.

Impact and influence

With an impact factor of 1.5 as reported by the Journal Citation Reports in 2022, the journal holds a respected position within the veterinary sciences category. It influences clinical guidelines, regulatory policies, and educational curricula worldwide. The publication is frequently cited in reports by the World Organisation for Animal Health and informs the work of pharmaceutical companies like Zoetis and Boehringer Ingelheim. Its research on topics such as pharmacogenomics and veterinary immunotherapy contributes to advancing One Health initiatives that link animal and human medicine.

Notable articles and special issues

The journal has published several landmark studies and dedicated special issues that have shaped the discipline. Notable contributions include pioneering work on fluoroquinolone pharmacokinetics in avian species, comprehensive reviews on non-steroidal anti-inflammatory drug safety in canine patients, and seminal papers on anthelmintic resistance in parasitology. Special issues have focused on critical themes like "Veterinary Pharmacology in Aquaculture" and "Advances in Veterinary Analgesia," often featuring proceedings from congresses of the International Association for Veterinary Pharmacology and Therapeutics.

Publication details

The journal is published bimonthly in six issues per volume by Wiley-Blackwell, a subsidiary of John Wiley & Sons, with editorial offices in Oxford and Hoboken, New Jersey. It operates under a hybrid open-access model, allowing authors to publish under traditional subscription or open-access terms. The print ISSN is 0140-7783, and the online ISSN is 1365-2885. Full-text archives are available on platforms like Wiley Online Library, and subscriptions are managed through agreements with numerous academic consortia and institutions globally.

Category:Veterinary medical journals Category:Pharmacology journals Category:English-language journals Category:Publications established in 1978 Category:Bimonthly journals